Log In
BCIQ
Print this Print this
 

IPP-203101

  Manage Alerts
Collapse Summary General Information
Company ImmuPharma plc
DescriptionPeptide-based antibiotic
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationStaphylococcus
Indication DetailsTreat methicillin-resistant Staphylococcus aureus (MSRA) infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today